Latex-Derived Peptides and Enzymes: Nature’s Answer to Antibiotic Resistance

September 11, 2025

Abstract The rapid rise of antimicrobial resistance has intensified the global search for alternatives to conventional antibiotics. Among the most promising candidates are antimicrobial peptides (AMPs), naturally occurring molecules with broad-spectrum activity and unique mechanisms that limit resistance development. Recent research highlights latex from medicinal plants as a rich but underexplored reservoir of AMPs, enzymes, […]

Next-Generation PROTACs: Peptide Strategies for Advanced Therapeutics

September 11, 2025

Abstract Proteolysis-targeting chimeras (PROTACs) have emerged as a transformative modality in drug discovery by leveraging the ubiquitin–proteasome system to selectively degrade disease-associated proteins. While small-molecule PROTACs have demonstrated success, their reliance on well-defined ligandable pockets leaves many clinically relevant proteins beyond reach. Peptide-based PROTACs (p-PROTACs) address this limitation by recognizing large protein–protein interaction (PPI) surfaces, […]

Smarter Drug Design: How Artificial Intelligence is Unlocking the Potential of PDCs

September 4, 2025

Abstract Peptide–drug conjugates (PDCs) are emerging as powerful tools in precision medicine, designed to deliver potent therapies directly to diseased tissues while sparing healthy cells. Unlike antibody–drug conjugates (ADCs), PDCs use small, flexible peptides as targeting agents, offering advantages such as deeper tissue penetration, lower immunogenicity, and reduced production costs. However, their development has lagged […]

A Century of Discovery: The Evolution of Insect Neuropeptide and Peptide Hormone Research

September 3, 2025

Abstract Insect neuropeptides and peptide hormones have been the subject of research for more than a century, evolving from early bioassays with crude extracts to modern genomic and structural approaches. Initially discovered as mysterious regulators of molting and reproduction, these small signaling molecules are now recognized as master regulators of insect physiology. They govern essential […]

Peptide Amphiphiles and Gene Therapy: Why Amorphous Nanostructures Outperform Fibrils

August 28, 2025

A New Twist in Viral Gene Delivery Gene therapy holds the promise of treating diseases at their source by rewriting faulty genetic instructions. Central to this approach are retroviral vectors—viruses repurposed to deliver therapeutic genes into human cells. Despite their potential, one major hurdle remains: getting these vectors to efficiently attach and enter target cells. […]

Unlocking the Undruggable: CPPTACs and the Future of Membrane Protein Therapies

August 28, 2025

Abstract Targeted protein degradation (TPD) has revolutionized modern drug discovery, yet plasma membrane proteins—critical in cancer, immunity, and metabolism—have remained stubbornly difficult to degrade. Traditional PROTACs act only on intracellular targets, while lysosome-based systems like LYTACs depend on tissue-specific receptors and suffer from efficiency limitations. A recent Nature Communications study introduces a novel solution: Cell-Penetrating […]

When Environment Becomes the Architect: Context Dependence in Peptide Self-Assembly

August 22, 2025

Abstract Peptide self-assembly has traditionally been understood through the framework of an “assembly code,” in which the primary sequence is thought to dictate supramolecular architecture. While this concept has enabled rational design of predictable nanostructures, growing evidence demonstrates that peptide assembly is profoundly context-dependent. Environmental variables—including pH, ionic strength, solvent conditions, and molecular crowding—reshape assembly […]

Is Semaglutide the Master Key for MASH? Mechanistic Insights and Clinical Evidence

August 22, 2025

Abstract Metabolic dysfunction–associated steatohepatitis (MASH) represents the progressive and clinically significant form of metabolic dysfunction–associated steatotic liver disease (MASLD), a condition now recognized as the most common cause of chronic liver disease worldwide. Closely linked to obesity, type 2 diabetes mellitus, and cardiovascular morbidity, MASH carries a substantial risk of cirrhosis, hepatocellular carcinoma, and mortality, […]

Stronger by Design: Peptide Nanorods Transform GelMA Hydrogels for Regenerative Medicine

August 14, 2025

Abstract Hydrogels such as gelatin methacryloyl (GelMA) hold great promise for regenerative medicine, offering biocompatibility, photocurability, and adaptability for in situ repair and 3D bioprinting. Yet, their inherent brittleness limits performance in load-bearing applications like cartilage and bone regeneration. Inspired by the mechanical resilience of intervertebral discs, researchers have developed a reinforcement strategy using peptide-based […]

Engineering Esc(1-21): Isopeptide Bond Positioning for Optimized Antimicrobial Performance

August 14, 2025

Abstract Antimicrobial peptides (AMPs) are promising candidates for combating multidrug-resistant pathogens, yet their therapeutic potential is often limited by host cytotoxicity and proteolytic instability. This study focuses on Esculentin-1a(1–21)NH₂ [Esc(1-21)], a frog-skin–derived AMP with potent Gram-negative activity, and explores a novel optimization strategy: site-specific incorporation of an isopeptide bond at selected lysine residues. Five analogs […]